Marketing-authorisation holder
Nova Laboratories Ltd
4 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| XALUPRINE 20 mg/ml SUSPENSION ORAL100 mg · Solución oral | Mercaptopurine | Spain | Authorised | 2013 |
| Luxturna | Voretigene neparvovec | Saudi Arabia | Authorised | |
| Xaluprine | Mercaptopurine | Saudi Arabia | Authorised | |
| XROMI | Hydroxycarbamide | Saudi Arabia | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 3 | 3 | 0 | CompaniesAll medicines |
| Spain | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- nova laboratories
- nova laboratories limited
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 2
- Roles
- Authorisation holder, manufacturer and marketer